Mark Jacobson | IR |
Herriot Tabuteau | CEO |
Nick Pizzie | CFO |
Lori Englebert | EVP, Commercial and Business Development |
Charles Duncan | Cantor Fitzgerald |
Raghuram Selvaraju | H.C. Wainwright |
Joon Lee | Truist Securities |
Jason Gerberry | Bank of America |
David Amsellem | Piper Sandler |
Vikram Purohit | Morgan Stanley |
Yatin Suneja | Guggenheim Partners |
Joseph Thome | TD Cowen |
Matt Kaplan | Ladenburg Thalmann |
Graig Suvannavejh | Mizuho Securities |
Myles Minter | William Blair |
Hello, and welcome to the Axsome Therapeutics Second Quarter Results Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
It's now my pleasure to turn the call over to Mark Jacobson, Chief Operating Officer at Axsome Therapeutics. Please go ahead, Mark.
Thank you, operator.